EP3539540
SGLT2 hindri 1-klór-4-(beta-D-glúkópýranós-1-ýl)-2-[4-((S)-tetrahýdrófúran-3-ýloxý)-bensýl]-bensen í samsetningu með insúlíni til notkunar í aðferð til að draga úr áhættunni á blóðsykurslækkun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.11.2011EP published:
18.12.2024EP application number:
19163940.0
EP translation filed:
19.3.2025Grant published:
15.4.2025EPO information:
European Patent Register
Max expiry date:
6.11.2031Expiry date:
6.11.2026Next due date:
30.11.2026
Title in English:
SGLT2 INHIBITOR 1-CHLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3- YLOXY)-BENZYL]-BENZENE IN COMBINATION WITH INSULIN FOR USE IN A METHOD FOR REDUCING THE RISK OF HYPOGLYCEMIALanguage of the patent:
English
Timeline
Today
7.11.2011EP application
18.12.2024EP Publication
19.3.2025Translation submitted
15.4.2025Registration published
6.11.2026Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
GREMPLER, RolfAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
JOHANSEN, Odd-ErikAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
KLEIN, ThomasAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
LUIPPOLD, GerdAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
MARK, MichaelAddress:
55216 INGELHEIM AM RHEIN, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
10190303Date:
8.11.2010Country:
EP
Number:
11151059Date:
17.1.2011Country:
EP
Classification
Categories:
A61K 31/341, A61K 31/00, A61K 38/28, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 11.11.2025
Expires: 6.11.2026
Payer: G.H. Sigurgeirsson ehf.